Cardinal Health, Inc.

Valuation Analysis

About the Company

Cardinal Health, Inc. en bref

Cardinal Health, Inc. (CAH) is currently trading at 193,32 € with a market capitalization of 45,3 Md €. The trailing P/E ratio stands at 33.91x, with a forward P/E of 18.49x. The 52-week range spans from 120,09 € to 203,64 €; the current price is 5.1% below the yearly high. Year-over-year revenue growth stands at +11.0%. The net profit margin stands at 0.62%.

💰 Dividende

Cardinal Health, Inc. pays an annual dividend of 1,79 € per share, representing a yield of 0.92%. The payout ratio stands at 31.19%.

📊 Avis des analystes

15 analystes évaluent Cardinal Health, Inc. (CAH) au consensus : Achat Fort. L'objectif de cours moyen est de 213,82 €, soit un potentiel de +10.6% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 187,43 € à 239,74 €.

Cardinal Health, Inc. : la thèse d'investissement en détail

Cardinal Health, Inc. (CAH) operates in the Healthcare — specifically Medical Distribution — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 11% pace year-over-year, suggesting the business model continues to find new customers and pricing power.

Le scénario baissier

With a net margin of just 0.62%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

The PEG ratio at 1.41 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 18.49x is meaningfully below the trailing 33.91x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Cardinal Health, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.